Pubblicati i risultati del bando JPND "Novel Imaging and Brain Stimulation Methods and Technologies Related to Neurodegenerative Diseases"

L'EU Joint Programme on Neurodegenerative Disease Research (JPND) ha deciso di finanziare 12 progetti di ricerca internazionali presentati in risposta al bando "Novel Imaging and Brain Stimulation Methods and Technologies", che potranno condurre alla realizzazione di una prevenzione e di terapie mirate e tempestive per i pazienti affetti da malattie neurodegenerative.

I dodici progetti, finalizzati allo sviluppo di nuove e avanzate tecnologie di imaging e di stimolazione cerebrale, sono stati raccomandati per il finanziamento da un Peer Review Panel indipendente e internazionale basato sull'eccellenza scientifica con il contributo del comitato consultivo del JPND relativamente al coinvolgimento dei pazienti e del pubblico.

I progetti selezionati sono:

• BioClotAD - Development of a neuroimaging biomarker to identify the pro-coagulant state in Alzheimer’s disease
• BRAINSTORM - gloBal RetinAl Imaging coNSorTium fOR alzheiMer’s disease
• DEBBIE - Developing a non-invasive biomarker for early BBB breakdown in Alzheimer’s disease
• DynaSti - Patient-specific dynamical modeling and optimization of Deep Brain Stimulation
• ImageTDP43 - Imaging heterogeneous TDP-43 neuropathologies
• NEURIPIDES - NEURofeedback for self-stImulation of the brain as therapy for ParkInson DisEaSe
• NIPARK - Targeting neuromelanin-linked neuronal dysfunction and degeneration in ageing and Parkinson’s disease using a combined imaging and brain stimulation approach
• NeuroPhage - Phage-based targeted neural stimulation in neurodegenerative diseases
• PDWALK - Spinal-cord stimulation technologies and methods to alleviate gait deficits of Parkinson’s disease
• PETABC - PET analyses of ABC transporter function for diagnostics and stratification of dementia patients
• REMOPD - Restoring Motor Functions in Parkinson’s Disease with Noninvasive Hybrid Transcranial Neuromodulation
• SCAIFIELD - Spinocerebellar ataxias: Advanced imaging with ultra-high field MRI.